VYOME HOLDINGS, INC. Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued
VYOME HOLDINGS, INC. (HIND) had Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued of $0 as of 2024-12-31, per its 10-K filed 2025-04-04.
Financial Statements › Balance Sheet › Liabilities › Accrued Liabilities
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued · last filed 2025-04-04
- 2024-12-31: Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued $0.00.
- 2023-12-31: Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued $0.00.
- 2022-12-31: Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued $0.00.
- 2021-12-31: Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued $0.00.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-04-04 |
| 2023-12-31 | $0.00 10-K · filed 2024-04-01 |
| 2022-12-31 | $0.00 10-K · filed 2023-04-17 |
| 2021-12-31 | $0.00 10-K · filed 2022-04-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |